Michael Lattanzi is an Oncology physician affiliated with Texas Oncology. OpenAlex indexes 27 publications with 964 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
30 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- JanssenProgram year202536 paymentsResearch$46,839openpaymentsdata.cms.gov ↗
- Daiichi SankyoProgram year20258 paymentsResearch$21,022openpaymentsdata.cms.gov ↗
- AbbVieProgram year20252 paymentsResearch$20,500openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Similar KOLs
Other experts from the same institution or the same specialty.
Noelle Cloven, MD
Texas Oncology
Charles Cowey, MD
Texas Oncology
Jeffrey Yorio, MD
Texas Oncology
Habte Yimer, MD
Texas Oncology
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”